🕒 Wednesday 30 April 2025 Wed, 30 Apr 2025

Nexus Minerals has raised A$8.1 million through an institutional placement led by North American investors, boosting its cash reserves to over A$12 million to accelerate exploration at the Wallbrook Gold Project in Western Australia.

Fin Resources Limited reported subdued exploration activity in Q1 2025 amid weak lithium prices but secured $445,000 via convertible notes and outlined plans for McKenzie Springs exploration.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

Zoono Group Limited reports strong progress in its shelf-life extension technology trials across multiple continents, with successful UK supermarket trials paving the way for a national roll-out in FY26. Despite a quarterly operating cash outflow, the company expects improved sales and sufficient funding to meet its near-term objectives.

Gas2Grid Limited moves closer to securing a new service contract in the Philippines while appealing a significant legal claim in France, all under the pressure of an impending ASX suspension deadline.

Inca Minerals has secured over 94% ownership of Stunalara Metals, gaining access to the promising Hurricane Project in North Queensland. With an oversubscribed $1.1 million capital raise, maiden drilling is set to begin in Q2 2025, targeting high-grade gold and antimony mineralisation.

Westgold Resources reported a record A$80 million increase in cash, bullion, and liquid investments in Q3 FY25, maintaining steady gold production and cost guidance while advancing key mine ramp-ups and strategic divestments.

Barton Gold Holdings reported a 120,000-ounce gold resource increase at Tunkillia and uncovered exceptional high-grade silver at Tarcoola’s Tolmer prospect, alongside a $3.1 million half-year profit and accelerated feasibility studies.

Silver Mines Limited reports steady progress on its flagship Bowdens Silver Project and initiates diamond drilling at the Elsienora Gold Project, while navigating complex regulatory hurdles in New South Wales.

Tesoro Gold Limited reported a challenging first quarter with significant cash outflows but has secured a substantial $11.1 million funding commitment to support ongoing exploration and operations.

Kalgoorlie Gold Mining’s March quarter was marked by a breakthrough Lighthorse gold discovery at the Pinjin Project, confirmed by RC drilling and supported by a strengthened balance sheet. The company is poised to expand exploration across its Laverton Tectonic Zone tenure.

European Lithium Limited reports a maiden 45 million tonne rare earth resource at its Greenland Tanbreez Project, alongside a $24.5 million capital raise by its majority-owned Critical Metals Corp, underpinning its global lithium and rare earth ambitions.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Jupiter Mines reported a robust Q3 FY2025 with higher manganese production and sales at Tshipi, driving a 65% jump in EBITDA amid improved prices and reduced costs.

Aldoro Resources Limited has had its trading suspension lifted immediately following the release of new exploration results and a response to an ASX price query, signaling renewed market activity.

Aldoro Resources has responded to an ASX price query by releasing partial exploration assay results after a significant share price jump, citing laboratory delays and confidentiality concerns as reasons for prior nondisclosure.

Aldoro Resources has reported significant assay results from its Kameelburg project in Namibia, confirming a large polymetallic deposit rich in rare earth elements, niobium, and molybdenum. The discovery, characterized by extensive mineralization and strategic metal zonation, is shaping up as a potential Tier 1 resource with strong commercial appeal.

Orthocell has secured Health Canada approval for its nerve repair product Remplir™, adding the US$75 million Canadian market and expanding its total addressable market to US$1.8 billion. The company plans to appoint local distributors and expects first sales in H2 2025.

Northern Minerals has made significant progress on its Browns Range Heavy Rare Earths Project, advancing its feasibility study and exploration while raising $41.5 million, positioning itself as a strategic alternative amid growing geopolitical supply risks.

Jade Gas Holdings has successfully drilled two production wells at Mongolia’s Red Lake gas field, confirming significant coal bed methane potential and preparing for imminent production. The company is advancing commercialisation talks with CNG manufacturers to capitalise on early gas flows.

AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.